Monday, October 25, 2021, 12:00 pm - 1:00 pm, PST
Online Only (Zoom Meeting)
Wolfram Goessling, M.D, Ph.D.
Robert H. Ebert Professor of Medicine
Harvard Medical School
Chief of Gastroenterology, Massachusetts General Hospital
Co-Director, Harvard-MIT Division of Health Sciences and Technology
Regulation of Liver Development and Growth
Speaker’s Research Interests: Dr. Goessling’s laboratory studies regulators of liver development to explore endodermal progenitor cell specification, organ differentiation, and growth. The main focus of the research is to understand the signals that indicate organ injury and regulate growth and regeneration. The inability to recover from acute injury can lead to organ failure, while a dysregulated regenerative response in the setting of chronic injury may contribute to cancer formation. Zebrafish is investigated as the primary model to discover novel regulatory pathways of liver development and evaluate their importance for recovery after toxic and physical injury.
Tuesday, November 30, 2021, 7:30 am to 8:30 am
Hashem B. El-Serag, M.D., M.P.H.
Chairman and Professor, Department of Medicine, Gastroenterology
Director, Texas Medical Center Digestive Diseases Center
Baylor College of Medicine
Speaker’s research Interests: Dr. El-Serag's research focuses on the epidemiology of digestive disorders, especially chronic liver disease, liver cancer and Barrett’s esophagus. His research was the first report of the rising trends in HCC incidence and its mortality and later work was among the first to report the connection between hepatitis C and HCC. His work on esophageal adenocarcinoma and its precursor lesion, Barrett’s esophagus, was important for reporting on rising GERD rates and the link between obesity and EAC, as well as for uncovering the inverse association between H pylori infection and the risk of Barrett’s esophagus and esophageal adenocarcinoma.
Monday, December 13, 2021
Eugene B. Chang, M.D.
Martin Boyer Distinguished Professor of Medicine
Director, Microbiome Medicine Program
Department of Medicine
Knapp Center for Biomedical Discovery
University of Chicago
Speaker’s Research Interests
: Dr. Chang’s research is directed towards gaining a better understanding of what factors are involved in the selection and assembly of intestinal microbes, and how they can be used to reshape the enteric microbiome to prevent and treat disease. The focus of Dr. Chang’s research is the study of host-microbe interactions in the context of human and mammalian systems and the bidirectional signaling processes that mediate these interactions.